The effects of ginger on type 2 diabetes

The effects of ginger on hypertention in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201111306278N2

Enrollment

Registered

2012-02-16

Start date

2011-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes

Interventions

Intervention 1: Intervention: capsules ginger 1 gr 3 times per day. Intervention 2: Control: capsules 1 gr microcristalin cellulose, 3 times per day.

Treatment - Drugs

Intervention: capsules ginger 1 gr 3 times per day

Control: capsules 1 gr microcristalin cellulose, 3 times per day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with type 2 diabetes ,patients newly diagnosed diabetes to 10 years, no pregnancy and lactation, lack of vitamin and mineral supplementation, without any thyroid , kidney , CVD diseases and not using TG & cholesterol lowering drugs,and also using ESTROGEN or PROGESTRON, FBS<180, 2Hpp<250 . Exclusion criteria: using insulin

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Systol Hypertention. Timepoint: Before - every two weeks during the intervention and after intervention. Method of measurement: mmhg.;Diastole Hypertention. Timepoint: Before - every two weeks during the intervention and after intervention. Method of measurement: mmhg.;Mean Arterial Pressure. Timepoint: Before - every two weeks during the intervention and after intervention. Method of measurement: mmhg.	—

Measure

Time frame

Systol Hypertention. Timepoint: Before - every two weeks during the intervention and after intervention. Method of measurement: mmhg.;Diastole Hypertention. Timepoint: Before - every two weeks during the intervention and after intervention. Method of measurement: mmhg.;Mean Arterial Pressure. Timepoint: Before - every two weeks during the intervention and after intervention. Method of measurement: mmhg.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehrouz Talaei Khales soflaei

University of Medical Sciences and Health Services

b.talaei@ssu.ac.ir b_talaei@hotmail.com+98 35 1724 0171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026